CELL THERAPY CATAPULT LIMITED

Supplier
We think CELL THERAPY CATAPULT LIMITED is a Government supplier specialising in
other professional, scientific and technical activities n.e.c..
We are tracking £106,021,644 in total UK government revenue, with £81,244,560 spent by Department for Business, Energy and Industrial Strategy as the largest purchaser. View on Companies House

Transactions

CELL THERAPY CATAPULT LIMITED has received £106,021,644 from 3 departments.

Income

Contracts

No contracts

We currently have no contracts recorded for CELL THERAPY CATAPULT LIMITED.
View all contracts

By department

Top departments

# Department Total spend
  1. 1

    Department for Business, Energy and Industrial Strategy

    2023–2025

    £81.2 Million

    ~£27.1M/yr
  2. 2

    DSIT

    2024–2025

    £24.5 Million

    ~£12.2M/yr
  3. 3

    Department for Levelling Up, Housing and Communities

    2023

    £300 Thousand

By organisation

Top organisations

# Organisation Total spend
  1. 1

    Innovate UK

    2023–2025

    £106 Million

    ~£35.2M/yr
  2. 2

    Department for Levelling Up, Housing and Communities

    2023

    £300 Thousand

By expense area

Top expense areas

# Expense area Total spend
  1. 1

    Project Knight

    Innovate UK · 2023–2025

    £41.7 Million

    ~£13.9M/yr

  2. 2

    Catapults - ASH&N

    Innovate UK · 2023–2024

    £28.8 Million

    ~£14.4M/yr

  3. 3

    Cell and Gene Therapy Catapult

    Innovate UK · 2024–2025

    £23.8 Million

    ~£11.9M/yr

  4. 4

    FER-HLS. Transforming Medicines Manufacturing

    Innovate UK · 2023–2025

    £4.31 Million

    ~£1.4M/yr

  5. 5

    No area specified

    Innovate UK · 2023

    £3.01 Million

  6. 6

    Centres for Advanced Therapies Training & Skills

    Innovate UK · 2023–2024

    £1 Million

    ~£500.8K/yr

  7. 7

    Biomedical Catalyst Programmes

    Innovate UK · 2023–2025

    £835 Thousand

    ~£278.2K/yr

  8. 8

    EU Operations

    Innovate UK · 2023–2025

    £690 Thousand

    ~£229.9K/yr

  9. 9

    FER-HLS Cancer Therapeutics

    Innovate UK · 2023–2025

    £636 Thousand

    ~£212K/yr

  10. 10

    Catapult CLN

    Innovate UK · 2025

    £575 Thousand

By expense type

Top expense types

# Expense type Total spend
  1. 1

    Resource grants

    Innovate UK · 2023–2025

    £103 Million

    ~£34.2M/yr

  2. 2

    No type specified

    Innovate UK · 2023

    £3.01 Million

  3. 3

    ERDF Work in Progress – Capital

    Department for Levelling Up, Housing and Communities · 2023

    £239 Thousand

  4. 4

    ERDF Work in Progress – Resource

    Department for Levelling Up, Housing and Communities · 2023

    £61.3 Thousand

Recent payments

Date Buyer Amount Expense area Expense type
2025-12-01
£1,746,284 Cell and Gene Therapy Catapult Resource grants
Resource grants
2025-12-01
£103,175 FER-HLS. Transforming Medicines Manufacturing Resource grants
Resource grants
2025-11-13
£11,535 Biomedical Catalyst Programmes Resource grants
Resource grants
2025-11-11
£6,785 Project Knight Resource grants
Resource grants
2025-11-06
£8,138 VPAG - Voluntary Scheme for Branded Medicine Pricing, Access and Growth Resource grants
Resource grants
2025-10-23
£52,329 Global - Europe Resource grants
Resource grants
2025-10-22
£2,166,456 Cell and Gene Therapy Catapult Resource grants
Resource grants
2025-10-22
£182,217 FER-HLS. Transforming Medicines Manufacturing Resource grants
Resource grants
2025-10-09
£111,175 Gov Health Life Science Reg Skills Resource grants
Resource grants
2025-10-09
£7,535 Launchpads Resource grants
Resource grants
2025-10-03
£59,448 FER-HLS. Transforming Medicines Manufacturing Resource grants
Resource grants
2025-09-19
£2,039,345 Cell and Gene Therapy Catapult Resource grants
Resource grants
2025-09-18
£79,286 FER-HLS. Transforming Medicines Manufacturing Resource grants
Resource grants
2025-09-18
£104,578 FER-HLS. Transforming Medicines Manufacturing Resource grants
Resource grants
2025-09-04
£17,358 VPAG - Voluntary Scheme for Branded Medicine Pricing, Access and Growth Resource grants
Resource grants
2025-09-01
£22,972 Biomedical Catalyst Programmes Resource grants
Resource grants
2025-08-21
£107,417 FER-HLS. Transforming Medicines Manufacturing Resource grants
Resource grants
2025-08-21
£52,631 FER-HLS. Transforming Medicines Manufacturing Resource grants
Resource grants
2025-08-20
£1,974,833 Cell and Gene Therapy Catapult Resource grants
Resource grants
2025-08-20
£73,105 FER-HLS. Transforming Medicines Manufacturing Resource grants
Resource grants

Showing 1 to 20 of 180 transactions

Frequently asked questions

What is the latest payment data available for CELL THERAPY CATAPULT LIMITED?

The most recent payment data we have available for CELL THERAPY CATAPULT LIMITED is from December 2025. Government departments and public bodies typically publish their spending data on a monthly or quarterly basis.

How has CELL THERAPY CATAPULT LIMITED's government income changed over time?

CELL THERAPY CATAPULT LIMITED's government income has decreased over time. In 2025, they received £27,093,231, compared to £39,923,935 in 2024 - a decrease of 32.1%.

How much has CELL THERAPY CATAPULT LIMITED received from the UK government?

CELL THERAPY CATAPULT LIMITED has received a total of £106,021,644 from UK government organisations according to our records. This income comes from 2 government buyers.

Which government departments buy from CELL THERAPY CATAPULT LIMITED?

The top government departments buying from CELL THERAPY CATAPULT LIMITED are Department for Business, Energy and Industrial Strategy (£81,244,560), DSIT (£24,476,923), and Department for Levelling Up, Housing and Communities (£300,162).

Company details

Company Number
07964711
Status
Active
Incorporated
2012-02-24
Type
PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)
Accounts
GROUP